Showing 171-180 of 10604 results for "".
Basosquamous Carcinoma: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basosquamous-carcinoma-a-case-series/23815/Basaloid carcinoma, a form of poorly differentiated squamous cell carcinoma, shares histologic similarities with basal cell carcinoma.Body Slimming: Exploring the Options
https://practicaldermatology.com/topics/practice-management/body-slimming-exploring-the-options/21112/Several experts share experiences and insights on the wide array of contouring devices.Pro Tip: Addressing Marginal Mandibular Nerve Paresis Following Submental Deoxycholate Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pro-tip-addressing-marginal-mandibular-nerve-paresis-following-submental-deoxycholate-injections/23734/An expert shares a simple fix to a potential unintended treatment outcome.A State of Transition for EHRs
https://practicaldermatology.com/topics/practice-management/a-state-of-transition-for-ehrs/22953/As practitioners await the next step in the larger implementation of this technology, an emphasis on utility is more important than ever.Clinical Focus: Acne: Back in the Spotlight: Effective Options for Truncal Acne
https://practicaldermatology.com/topics/general-topics/back-in-the-spotlight-effective-options-for-truncal-acne/22031/Data suggest that patients may be unlikely to report truncal acne. Clinicians must assess chest and back involvement and be prepared to offer effective treatments.Look to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.Cosmeceuticals: Sunscreens
https://practicaldermatology.com/topics/general-topics/cosmeceuticals-sunscreens/21366/What you should know about the FDA's final ruling on sunscreen products and tips for understanding the variety of sun protection ingredients available to make more informed recommendations to patients.Statins and Skin Cancer: The Latest Data
https://practicaldermatology.com/topics/skin-cancer-photoprotection/statins-and-skin-cancer-the-latest-data/20426/A look at another commonly used drug and its potential association with skin cancer risks.Dupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects sThe Excimer Laser for Psoriasis: A Review of Safety and Efficacy
https://practicaldermatology.com/topics/practice-management/the-excimer-laser-for-psoriasis-a-review-of-safety-and-efficacy/21883/Specialists describe the evolving role of the excimer laser in treating psoriasis.